The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125299784 12529978 4 F 201606 20160802 20160706 20160805 EXP GB-AMGEN-GBRSP2016077262 AMGEN 69.00 YR E F Y 0.00000 20160805 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125299784 12529978 1 PS NEULASTA PEGFILGRASTIM 1 Subcutaneous 6 MG, 1/1 CYCLICAL 125031 6 MG UNKNOWN FORMULATION
125299784 12529978 2 SS NEULASTA PEGFILGRASTIM 1 Subcutaneous UNK UNK, 1/1 CYCLICAL 125031 UNKNOWN FORMULATION
125299784 12529978 3 SS EMEND APREPITANT 1 Oral 125 MG, 1/1 CYCLICAL 0 125 MG
125299784 12529978 4 SS DEXAMETHASONE. DEXAMETHASONE 1 Intravenous (not otherwise specified) 8 MG, 1/1 CYCLICAL 0 8 MG
125299784 12529978 5 SS ONDANSETRAN ONDANSETRON HYDROCHLORIDE 1 Intravenous (not otherwise specified) 8 MG, 1/1 CYCLICAL 0 8 MG
125299784 12529978 6 SS EPIRUBICIN EPIRUBICIN 1 Intravenous (not otherwise specified) 126 MG, 1/1 CYCLICAL 0 126 MG
125299784 12529978 7 SS FLUOROURACIL. FLUOROURACIL 1 Intravenous (not otherwise specified) 1008 MG, 1/1 CYCLICAL 0 1008 MG
125299784 12529978 8 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 0.9 MG, UNK 0 .9 MG INJECTION
125299784 12529978 9 SS METOCLOPRAMIDE. METOCLOPRAMIDE 1 Unknown UNK, 1/1 CYCLICAL 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125299784 12529978 1 Breast cancer
125299784 12529978 3 Product used for unknown indication
125299784 12529978 4 Product used for unknown indication
125299784 12529978 5 Product used for unknown indication
125299784 12529978 6 Breast cancer
125299784 12529978 7 Breast cancer
125299784 12529978 8 Breast cancer
125299784 12529978 9 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125299784 12529978 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125299784 12529978 Alopecia
125299784 12529978 Body temperature abnormal
125299784 12529978 Condition aggravated
125299784 12529978 Cough
125299784 12529978 Diarrhoea
125299784 12529978 Dry mouth
125299784 12529978 Dyspnoea
125299784 12529978 Ear pain
125299784 12529978 Eating disorder
125299784 12529978 Fatigue
125299784 12529978 Feeling abnormal
125299784 12529978 Glossodynia
125299784 12529978 Headache
125299784 12529978 Hypophagia
125299784 12529978 Intercepted drug administration error
125299784 12529978 Lethargy
125299784 12529978 Lower respiratory tract infection
125299784 12529978 Malaise
125299784 12529978 Nausea
125299784 12529978 Odynophagia
125299784 12529978 Oral pain
125299784 12529978 Oropharyngeal pain
125299784 12529978 Pharyngeal erythema
125299784 12529978 Productive cough
125299784 12529978 Sputum discoloured
125299784 12529978 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125299784 12529978 6 20160608 0
125299784 12529978 7 20160608 0
125299784 12529978 8 20160608 0